Genetic testing has never been more accessible. Direct-to-consumer kits, hospital-ordered panels, and whole genome sequencing programs are putting DNA data in the hands of millions of people every year. But there is a significant gap between receiving a genetic test result and understanding what it actually means for your health.
Table of Contents
A positive finding on a genetic test is not a diagnosis. A negative result is not a guarantee. And the most common outcome — a variant of uncertain significance — is neither good news nor bad news, which is precisely what makes it so difficult to navigate.
Understanding what happens between the lab and your physician’s office can help you ask better questions, make more informed decisions, and put genetic findings in the right context for your long-term health.
How DNA Testing Actually Works
When you submit a sample for genetic testing — whether saliva, blood, or tissue — it goes through a sequencing process that reads the chemical letters of your DNA. Modern next generation sequencing technology can scan anywhere from a targeted set of genes to your entire genome in a matter of days.
But sequencing is only the beginning. The raw output of a sequencing run is not a report — it is an enormous file of data containing millions of positions in your genome, each compared against a human reference. The process of turning that raw data into something clinically meaningful is called NGS analysis, and it involves multiple computational and clinical steps before a result ever reaches a physician or patient.
Most people assume that a DNA test works like a blood glucose reading — a number comes back, and it either is or isn’t within range. Genetic test results are rarely that simple. The complexity starts with the sheer volume: a whole genome contains roughly 4 to 5 million positions where your DNA differs from the reference sequence. The challenge is determining which of those differences matter.
What “Finding Something” Actually Means
When a lab reports a genetic finding, it has already done a significant amount of filtering. Of the millions of variants in your genome, the vast majority are common, benign differences shared by large portions of the population. Labs focus on variants that are rare, that occur in genes known to cause disease, and that have characteristics suggesting they might disrupt normal gene function.
Even after that filtering, genetic test findings fall into one of five categories:
Pathogenic — the variant is established as disease-causing based on strong evidence.
Likely pathogenic — evidence strongly suggests the variant causes disease, but full confirmation is pending.
Variant of uncertain significance (VUS) — the variant has been identified but current evidence is insufficient to classify it as harmful or harmless.
Likely benign — evidence suggests the variant is probably not disease-causing.
Benign — the variant is established as clinically insignificant.
The category a variant lands in is not arbitrary. It is determined through a structured evidence-weighing process known as genome interpretation — one of the most technically and intellectually demanding stages of clinical genomics.
Why Genome Interpretation Is So Complex
Classifying a variant requires answering four fundamental questions: Is the variant real, or a sequencing artifact? Is it rare enough to be potentially disease-causing? Does it disrupt how a gene functions? And does it fit the patient’s clinical picture?
Each of those questions draws on different sources of evidence — population frequency databases, functional studies, clinical case literature, inheritance patterns within families, and computational predictions. No single data point is sufficient. Classification requires integrating all of them, and weighing each according to standardized frameworks developed by bodies like the American College of Medical Genetics and Genomics (ACMG).
This is why two labs can sometimes reach different conclusions about the same variant. The evidence base for most variants is incomplete and evolving. A variant classified as uncertain today may be reclassified as pathogenic or benign within a few years as more data becomes available — which is why many labs have active reclassification programs and may contact patients when a finding’s status changes.
The VUS Problem — and Why It Matters for Your Health
Variants of uncertain significance are the most common outcome in many types of genetic testing, particularly for rare disease and hereditary cancer panels. Studies suggest that between 30 and 50 percent of whole exome sequencing results in rare disease include at least one VUS.
This creates a real challenge for patients and physicians alike. A VUS is not a diagnosis. Acting on it as though it were — pursuing invasive screening, making reproductive decisions, or experiencing prolonged anxiety — is not warranted by the genetic test evidence. Ignoring it entirely is also not the right approach, since the classification may change.
The practical guidance from most geneticists: document the VUS, ensure it is on record with the testing lab for future reclassification, and revisit it periodically — especially if new symptoms emerge or family history becomes clearer. A genetic counselor is often the most useful resource for navigating an uncertain genetic test result, translating what the finding does and does not mean in practical terms.
What a Negative Result Does and Doesn’t Tell You
A negative genetic test — no pathogenic or likely pathogenic variants found — is often reassuring, but its meaning depends heavily on what was tested. A panel that screens 30 genes associated with hereditary breast cancer will miss variants in genes not on that panel. A whole exome test covers protein-coding regions but misses structural changes and variants in non-coding DNA. A whole genome test is the most comprehensive option currently available, but even it cannot detect every type of genetic change.
Negative genetic test results also don’t account for non-genetic contributions to disease. Most common conditions — heart disease, type 2 diabetes, many cancers — are influenced by a combination of many genetic variants, lifestyle, and environment. A clean hereditary panel does not mean zero risk. It means the specific inherited variants associated with high risk in well-studied genes were not detected.
Genetic Testing and Aging: Why This Matters More Over Time
The relevance of genetic testing in the context of aging and longevity is growing. Hereditary conditions that increase cancer risk, cardiovascular disease, or neurodegeneration often have decades-long windows between genetic predisposition and clinical disease — windows where intervention can meaningfully change outcomes.
Early identification of a BRCA1 or BRCA2 variant, for example, allows for enhanced screening and preventive options that can significantly reduce lifetime cancer risk. Variants linked to hereditary heart conditions can prompt earlier monitoring and lifestyle changes. Pharmacogenomic findings — how your genes affect drug metabolism — can inform safer, more effective medication choices as prescription burden typically increases with age.
None of this requires a positive finding to be valuable. Understanding what your genome does and doesn’t tell you is itself useful health information, and it becomes more so as genetic medicine continues to advance.
Questions Worth Asking Your Physician
If you have received or are considering genetic testing, these questions can help you get more out of the conversation:
● What specific genes or regions does this test cover — and what does it miss?
● If a VUS is found, what is the lab’s policy on reclassification and patient notification?
● Would a genetic counselor be involved in interpreting the results?
● How will this result change my clinical management, if at all?
● Should other family members be tested based on this finding?
Genetic testing is a powerful tool. But like most powerful tools, its value depends almost entirely on how well its results are understood and applied. A finding is a starting point — not a verdict.
As with anything you read on the internet, this article should not be construed as medical advice; please talk to your doctor or primary care provider before changing your wellness routine. WHN neither agrees nor disagrees with any of the materials posted. This article is not intended to provide a medical diagnosis, recommendation, treatment, or endorsement.
Opinion Disclaimer: The views and opinions expressed in this article are those of the author and do not necessarily reflect the official policy of WHN. Any content provided by guest authors is of their own opinion and is not intended to malign any religion, ethnic group, club, organization, company, individual, or anyone or anything else. The Food and Drug Administration has not evaluated these statements.
